Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 3/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CASP6 | P55212 | 1/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 2/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGAV | P06756 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.40 |
| ▸ | RXRA | P19793 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | SHBG | P04278 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26262146 | 0.91 | SHBG (0.50) | TTRACHEKDM4ECASP6ALB | |
| SCHEMBL9467420 | 0.83 | TRPV1 (0.50) | KDM4ELMNARPS6KA3HSD17B10PDE4D | |
| SCHEMBL26056808 | 0.81 | ACHE (0.42) | TTRACHEKDM4ECASP6SHBG | |
| SCHEMBL25368629 | 0.80 | ACHE (0.46) | ACHEKDM4ECASP6TBXA2RADRB2 | |
| SCHEMBL8773681 | 0.79 | TTR (0.48) | TTRKDM4EALBTHRBITGB3 | |
| SCHEMBL1126255 | 0.78 | TTR (0.52) | TTRALBTHRBITGB3ITGAV | |
| SCHEMBL6103705 | 0.76 | TTR (0.50) | TTRALBTHRBITGB3ITGAV | |
| SCHEMBL28223321 | 0.75 | MAPT (0.50) | TTRACHETHRBITGB3ITGAV | |
| SCHEMBL12514479 | 0.74 | TTR (0.48) | TTRALBTHRBITGB3ITGAV | |
| SCHEMBL670778 | 0.72 | SHBG (0.58) | ACHEKDM4ECASP6LMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680599-A1 | PROCESS FOR THE SYNTHESIS OF THE COMPOUND 5,7-DIIODO-1-OXASPIRO[2,5]OCTA-4,7-DIEN-6-ONE | Innoverda (FR) | 2026-01-21 | — | — | EP | claimed |
| WO-2024189137-A1 | PROCESS FOR THE SYNTHESIS OF THE COMPOUND 5,7-DIIODO-1-OXASPIRO[2,5]OCTA-4,7-DIEN-6-ONE | INNOVERDA (FR) | 2024-09-19 | — | — | WO | claimed |
| EP-4211104-B1 | PROCESS FOR THE SYNTHESIS OF 3,5-DIIODO-4-HYDROXYBENZYL ALCOHOL | INNOVERDA (FR) | 2024-07-03 | — | — | EP | claimed |
| US-11834396-B2 | Method for synthesizing 3,5-diiodo-4-hydroxy benzyl alcohol | INNOVERDA (FR) | 2023-12-05 | — | — | US | claimed |
| US-20230286890-A1 | METHOD FOR SYNTHESIZING 3,5-DIIODO-4-HYDROXY BENZYL ALCOHOL | DIVERCHIM CDMO (FR) | 2023-09-14 | — | — | US | claimed |
| EP-4211104-A1 | PROCESS FOR THE SYNTHESIS OF 3,5-DIIODO-4-HYDROXYBENZYL ALCOHOL | Innoverda (FR) | 2023-07-19 | — | — | EP | claimed |
| WO-2022053418-A1 | PROCESS FOR THE SYNTHESIS OF 3,5-DIIODO-4-HYDROXYBENZYL ALCOHOL | INNOVERDA (FR) | 2022-03-17 | — | — | WO | claimed |
| CN-122070309-A | Composition, resin composition, film-forming composition for lithography, and resist film-forming composition | 三菱瓦斯化学株式会社 | 2026-05-19 | — | — | CN | disclosed |
| EP-4680599-A1 | PROCESS FOR THE SYNTHESIS OF THE COMPOUND 5,7-DIIODO-1-OXASPIRO[2,5]OCTA-4,7-DIEN-6-ONE | Innoverda (FR) | 2026-01-21 | — | — | EP | disclosed |
| EP-4680599-A1 | PROCESS FOR THE SYNTHESIS OF THE COMPOUND 5,7-DIIODO-1-OXASPIRO[2,5]OCTA-4,7-DIEN-6-ONE | Innoverda (FR) | 2026-01-21 | — | — | EP | disclosed |
| US-20250250216-A1 | CYCLIC COMPOUND HAVING IODINE ATOM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-08-07 | — | — | US | disclosed |
| CN-120136704-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| CN-120136703-A | Compound, polymer, composition for film formation, pattern formation method, method for forming insulating film, and method for producing compound | 三菱瓦斯化学株式会社 | 2025-06-13 | — | — | CN | disclosed |
| WO-2021029396-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, AND PATTERN FORMING METHOD | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| WO-2021029396-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, AND PATTERN FORMING METHOD | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| WO-2021029395-A1 | COMPOUND, POLYMER, COMPOSITION, COMPOSITION FOR FILM FORMATION, PATTERN FORMING METHOD, METHOD FOR FORMING INSULATING FILM, METHOD FOR PRODUCING COMPOUND, IODINE-CONTAINING VINYL POLYMER AND METHOD FOR PRODUCING ACETYLATED DERIVATIVE OF SAME | 三菱瓦斯化学株式会社 | 2021-02-18 | — | — | WO | disclosed |
| WO-2020137935-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, PATTERN FORMING METHOD, AND COMPOUND PRODUCTION METHOD | 三菱瓦斯化学株式会社 | 2020-07-02 | — | — | WO | disclosed |
| WO-2020137935-A1 | COMPOUND, (CO)POLYMER, COMPOSITION, PATTERN FORMING METHOD, AND COMPOUND PRODUCTION METHOD | 三菱瓦斯化学株式会社 | 2020-07-02 | — | — | WO | disclosed |
| EP-0802798-A1 | METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS | CHIRON CORPORATION (US) | 1997-10-29 | — | — | EP | disclosed |
| WO-1995022992-A1 | METHOD AND COMPOSITIONS FOR INCREASING THE SERUM HALF-LIFE OF PHARMACOLOGICALLY ACTIVE AGENTS | CHIRON CORPORATION (US) | 1995-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250250216-A1 | CYCLIC COMPOUND HAVING IODINE ATOM | IGF1R, SSTR1, CCNI | TTR 2566/4885ACHE 3558/4885KDM4E 4444/4885 |
| US-20230286890-A1 | METHOD FOR SYNTHESIZING 3,5-DIIODO-4-HYDROXY BENZYL ALCOHOL | ADH1C, ADH5, ADH1A | TTR 2169/4885ACHE 3410/4885KDM4E 369/4885 |
| US-11834396-B2 | Method for synthesizing 3,5-diiodo-4-hydroxy benzyl alcohol | ADH1C, ADH5, ADH1A | TTR 2169/4885ACHE 3410/4885KDM4E 369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.